GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (OTCPK:ITHUF) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

iAnthus Capital Holdings (iAnthus Capital Holdings) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of May. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.


Competitive Comparison of iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.



iAnthus Capital Holdings  (OTCPK:ITHUF) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


iAnthus Capital Holdings EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.


iAnthus Capital Holdings (iAnthus Capital Holdings) Business Description

Industry
Traded in Other Exchanges
Address
420 Lexington Avenue, Suite 414, New York, NY, USA, 10170
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Proud Richard C. Jr. director, officer: CEO and Director 8253 PARSONS PASS, NEW ALBANY OH 43054
Alexander Shoghi director SUITE 1550, 300 WEST 6TH STREET, AUSTIN TX 78701
John Alexander Paterson director 2 WENDIGO WAY, TORONTO A6 M6S2T9
Gotham Green Partners Llc 10 percent owner 1437 4TH STREET, SANTA MONICA CA 90401
Philippe Faraut officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Kenneth W Gilbert director C/O THE WENDY'S COMPANY, ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Julius Kalcevich officer: Chief Financial Officer 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Robert R Galvin officer: Interim CEO and COO
Senvest Management, Llc director, 10 percent owner, other: (See Remarks) 540 MADISON AVENUE, 32ND FLOOR, NEW YORK NY 10022
Marco Dattanasio director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Scott Herman Cohen director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Zachary Arrick director 420 LEXINGTON AVENUE, SUITE 414, NEW YORK NY 10170
Mich J Mathews-spradlin director ONE DAVE THOMAS BLVD., DUBLIN OH 43017
Oasis Investments Ii Master Fund Ltd. 10 percent owner UGLAND HOUSE PO BOX 309, GRAND CAYMAN E9 KY1-1104
Seth Fischer 10 percent owner C/O OASIS MANAGEMENT (HONG KONG) LLC, 21/F MAN YEE BUILDING, 68 DES VOEUX ROAD, CENTRAL K3